Last Updated: November 8, 2026

Biovail Company Profile

« Back to Dashboard

What is the competitive landscape for BIOVAIL

BIOVAIL has ten approved drugs.

Summary for Biovail

US Patents:	0
Tradenames:	8
Ingredients:	6
NDAs:	10
Patent Litigation for Biovail:	See patent lawsuits for Biovail

Drugs and US Patents for Biovail

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Biovail Labs Intl	CARDIZEM	diltiazem hydrochloride	INJECTABLE;INJECTION	020027-003	Aug 18, 1995		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Biovail	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	074845-003	Sep 15, 1999		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Biovail	ISORDIL	isosorbide dinitrate	TABLET;SUBLINGUAL	012940-003	Jul 29, 1988		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Biovail Labs Intl	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET, ORALLY DISINTEGRATING;ORAL	021763-001	Dec 20, 2005		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Biovail

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Biovail	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020939-003	Jan 28, 2000	5,529,791	⤷ Start Trial
Biovail	CARDIZEM SR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	019471-004	Jan 23, 1989	4,721,619	⤷ Start Trial
Biovail	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020939-002	Jan 28, 2000	5,529,791	⤷ Start Trial
Biovail	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020939-004	Jan 28, 2000	5,288,505	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.